We need to understand the dosing regime, given we know the retinal damage previously caused by elmiron and the ongoing liability it faces in the US right now.
We need to understand the dosing regime, given we know the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.8¢ | 23.0¢ | $153.9K | 656.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 365364 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 901 | 1 |
View Market Depth
| Last trade - 15.59pm 26/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |